Key takeaways
- Better nutrition in the GLP-1 era means more nutrition per bite, not more food.
- Five principles matter most: nutrient density, easy protein, tolerability, simplicity and honesty about evidence.
- "GLP-1 friendly" is a marketing phrase, not a standard. Look at what a product actually delivers per serving.
- Plenty is still unknown, and the people living this change should help shape what gets built.
Every so often, something changes how a lot of people eat all at once. Refrigeration did. Supermarkets did. We think GLP-1 medications are one of those moments, and that nutrition hasn't caught up yet.
This is our perspective on what "better" should mean now. It's opinionated, and it's written by a company that hasn't launched, so read it with that in mind.
A new kind of eater
GLP-1 medications have created a large and growing group of people who eat far less than before, often without effort, and whose nutrition needs haven't shrunk to match. A KFF poll in May 2024 found that about one in eight U.S. adults said they had ever taken a GLP-1 medication, and use has kept growing since.
These people aren't dieting in the traditional sense. They're not fighting hunger; many are trying to remember to eat at all. That's a different problem from the one most nutrition products were designed to solve, and it calls for a different answer. We laid out the core of it in Eating Less Changes More Than Appetite.
What the category gets wrong
Most nutrition products were built for people trying to eat less, or for athletes trying to eat more. Neither fits someone whose appetite has already been turned down. A few patterns stand out:
- Volume over density. Large, thick shakes and heavy bars assume room in the stomach that many GLP-1 users no longer have.
- Labels over substance. "GLP-1 friendly" has appeared on packaging quickly, but it isn't a regulated term, and it doesn't tell you what's inside.
- Complexity as a feature. Long ingredient lists and multi-step routines ask a lot of someone who's already managing a medication and its side effects.
- Promises ahead of evidence. Claims tend to move faster than research. That's a problem in a space this close to people's health.
What we think better looks like
Here's where we've landed so far. These are the principles guiding our approach, and we expect to keep refining them.
1. More nutrition per bite
When quantity falls, density has to rise. Better nutrition fits meaningful amounts of protein, fiber, fluids and micronutrients into small servings, instead of asking people to eat or drink more than they comfortably can.
2. Protein that's easy to take
Protein is one of the most important things to protect when people eat less, and one of the hardest to eat when you're full. Formats that drink light and sit comfortably, rather than thick and heavy, make the difference between a good intention and a daily habit.
3. Gentle by design
Nausea, fullness and constipation are common on GLP-1s. Better nutrition takes tolerability seriously: gradual fiber, ingredients chosen for how they sit, and nothing that makes a sensitive stomach work harder than it has to.
4. Simple enough to keep doing
The best routine is the one people keep. That means fewer steps, clear amounts and a structure built around the gaps that matter most: protein, fiber and hydration, with foundational vitamins and minerals underneath.
5. Honest about the evidence
Every ingredient should have a reason to be there, and that reason should be explainable in plain language. Where the evidence is strong, say so. Where it's early, say that too.
What we're still unsure about
A lot, honestly. GLP-1 medications are well studied for weight and metabolic outcomes, but research on the best everyday nutrition for people taking them is newer and still developing. A few questions we're thinking about:
- How much individual needs vary. Age, dose, activity and side effects differ widely. One formula won't fit everyone.
- What changes over time. Needs in the first months may look different from needs a year in, or after someone stops the medication.
- What people actually want. Drinks or food? One product or a system? We have hypotheses, not answers.
That last question is why we're asking people directly before we decide what to build first.
Where we go from here
We think the next generation of nutrition will be defined less by how much it contains and more by how well it fits the way people now eat. Smaller, denser, gentler, clearer.
Nuravita is being built toward that: a nutrition system around hydration, fiber, protein and foundational nutrients for people whose eating has changed. We haven't launched yet, so we won't ask you to trust us. We'd rather show our thinking and earn it.
Frequently asked questions
Is there a special diet for people taking GLP-1 medications?There is no single official GLP-1 diet. Published guidance generally emphasizes enough protein, fiber and fluids, nutrient-dense whole foods, smaller and more frequent meals if needed, and regular physical activity, including resistance exercise. A clinician or registered dietitian can tailor this to the individual.
What does "GLP-1 friendly" mean on a food label?It is a marketing phrase, not a regulated term, so its meaning depends on the brand. A useful test is whether the product delivers meaningful protein, fiber or micronutrients in a small, easy-to-tolerate serving, with clear amounts on the label.
What is Nuravita?Nuravita is a nutrition brand in development for people whose appetite and eating patterns have changed. It is being built around hydration, fiber, protein and foundational nutrients, and early-access members help decide what comes first. It has not launched yet.
Sources and further reading
- KFF. KFF Health Tracking Poll, May 2024: use of GLP-1 drugs among U.S. adults.
- Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society. 2025.
- U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans, 2020–2025.
- U.S. Food and Drug Administration. Prescribing information for semaglutide and tirzepatide products (adverse reactions: gastrointestinal).
About the Nuravita Journal. Nuravita is a nutrition brand in development for people whose eating has changed. Journal articles are written by our editorial team for general education, drawing on the published guidance listed above. We update articles when the evidence changes.
This article is for general information only and isn't medical advice. Talk to your prescriber or a registered dietitian before changing your diet, medication or supplements.
